Human medicines European public assessment report (EPAR): Enyglid, repaglinide, Date of authorisation: 13/10/2009, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Nivestim, filgrastim, Date of authorisation: 07/06/2010, Revision: 31, Status: Authorised

Appendix 1: Acceptable intakes established for N-nitrosamines

Appendix 1: Acceptable intakes established for N-nitrosamines

Appendix 1: Acceptable intakes established for N-nitrosamines

Human medicines European public assessment report (EPAR): Repaglinide Krka, repaglinide, Date of authorisation: 03/11/2009, Revision: 9, Status: Authorised

Questions and answers clinic on post-authorisation procedure management in IRIS, Online, from 8 January 2025, 14:00 (CET) to 8 January 2025, 15:00 (CET)

Methodology Working Party

Vaccines Working Party

3Rs Working Party